The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype Full article: Compounded glucagon like peptide 1 receptor agonists for weight loss: the direct to consumer market in Colorado FDA to weigh easing limits on unproven peptides promoted by RFK Jr. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York